## Core Concept
The measles vaccine is a live, attenuated vaccine that provides immunity against measles, a highly contagious viral disease. The vaccine's efficacy is crucial for preventing measles outbreaks, particularly in areas with low vaccination coverage. The administration of a second dose of the measles vaccine is a strategy to increase the overall immunity in a population.

## Why the Correct Answer is Right
The efficacy of the measles vaccine after the second dose is significantly high, generally reported to be around 97-99%. This high efficacy rate is due to the vaccine's ability to induce a strong immune response, characterized by the production of neutralizing antibodies and cell-mediated immunity. The second dose of the measles vaccine serves to ensure that individuals who did not respond to the first dose (due to various factors such as vaccine failure or lack of exposure) develop immunity.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it suggests a much lower efficacy rate than what is documented for the measles vaccine after the second dose.
- **Option B:** Similarly, this option underestimates the efficacy of the measles vaccine after the second dose.
- **Option D:** This option overestimates the efficacy, which, although high, does not reach the level of 100%.

## Clinical Pearl / High-Yield Fact
A key point to remember is that the measles vaccine is highly effective, with an estimated efficacy of 93% after the first dose and 97% after the second dose. This vaccine is crucial for preventing measles and its complications, particularly in high-risk populations.

**Correct Answer: C. 97%**